Nothing on this website constitutes, or should be interpreted as, medical advice, clinical guidance, diagnosis, treatment recommendations, or prescribing decisions
GLP- 1 Receptor Agonists for the Treatment of Obesity Liraglutide Liraglutide at a high dose of 3 mg daily is approved for long-term weight control in adults and children over the age of 12 with obesity or overweight plus at least one weight-related comorbidity
J Epidemiol Commun Health
They also ease joint pain by reducing inflammation and mechanical stress on joints, offering relief for conditions like osteoarthritis
Patients should contact their prescriber if nausea is severe, persistent beyond the expected adjustment window, prevents adequate oral intake, or if symptoms are accompanied by alarming signs like significant weight loss or dehydration
Wilson JM, Lin Y, Luo MJ, et al